Indications and uses
healthcare personnel handwash : helps reduce bacteria that potentially can cause disease skin wound and general skin cleansing
healthcare personnel handwash : helps reduce bacteria that potentially can cause disease skin wound and general skin cleansing
use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns. Healthcare personnel handwash: wet hands with water dispense about 5ml of product into cupped hands and wash in a vigorous manner for about 15 seconds rinse and dry thoroughly Skin wound and normal skin cleansing: thoroughly rinse the area to be cleaned with water apply the minimum amount of ...
store at 20°-25° C (68°-77° F) avoid excessive heat above 40° C (104° F)
Chlorhexidine gluconate 4% solution
Antiseptic
For external use only
Allergy alert:
This product may cause a severe allergic reaction. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away
If swallowed, get medical help or contact a Poison Control center right away
irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.
Healthcare personnel handwash:
Skin wound and normal skin cleansing:
cocamide DEA, fragrance, glucono-delta-lactone, hydroxyethylcellulose, isopropyl alcohol, lauramine oxide, PEG-75 lanolin, purified water, tridecyl alcohol.
1-800-587-3721
DO NOT USE IF SAFETY SEAL IS BROKEN OR MISSING
Warning: This product contains a chemical (cocamide DEA) known to the State of California to cause cancer.
Laundering/Cleaning Instructions: Chlorhexidine gluconate skin cleansers will cause stains if used with chlorine releasing products. Rinse completely and use only non-chlorine detergents.
*This product is not manufactured or distributed by Mölnlycke Healthcare, owner of the registered trademark Hibiclens®.
Warning: Cancer -
www.P65Warnings.gov
Laundering/Cleaning Instructions: Chlorhexidine gluconate skin cleansers will cause stains if used with chlorine releasing products, such as chlorine bleach.
*This product is not manufactured or distributed by Mölnlycke Healthcare, owner of the registered trademark Hibiclens®.
Quality Choice
NDC 63868-940-08
Compare to the active ingredient in HIBICLENS®*
Antiseptic Skin Cleanser
Antiseptic/Antimicrobial Skin Cleanser
Chlorhexidine Gluconate 4% Solution
Reduces Bacteria on the Skin
Net Contents: 8FL OZ (237 mL) BOTTLE
FOR EXTERNAL USE ONLY
DYE FREE
1061QC08LBLG
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 211365 | chlorhexidine gluconate 4 % Medicated Liquid Soap | PSN | 7 |
| 211365 | chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap | SCD | 7 |
| 211365 | chlorhexidine gluconate 4 % Medicated Liquid Soap | SY | 7 |
| 211365 | chlorhexidine gluconate 4 % Medicated Surgical Scrub | SY | 7 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORHEXIDINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0635515967571 | GTIN-13: 0635515967571 EAN-13: 0635515967571 GTIN-12: 635515967571 UPC-A: 635515967571 GTIN storage (14 digits): 00635515967571 | QC Blank .jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63868-940-08 | Antiseptic Skin Cleanser | 237 mL in 1 BOTTLE, PLASTIC | LIQUID | 237 | 7 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63868-940-08 | ML - Milliliter | 63868-940 | 9e2e9bed-56a3-4fa5-b62c-9a2008bbe900 | 1 | 2022-10-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CHLORHEXIDINE GLUCONATE | ACTIVE INGREDIENT | MOR84MUD8E | 2 | |
| CHLORHEXIDINE | ACTIVE MOIETY | R4KO0DY52L | 2 | |
| COCO DIETHANOLAMIDE | INACTIVE INGREDIENT | 92005F972D | 2 | |
| GLUCONOLACTONE | INACTIVE INGREDIENT | WQ29KQ9POT | 2 | |
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | INACTIVE INGREDIENT | S38J6RZN16 | 2 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | 2 | |
| PEG-75 LANOLIN | INACTIVE INGREDIENT | 09179OX7TB | 2 | |
| TRIDECYL ALCOHOL | INACTIVE INGREDIENT | 8I9428H868 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63868-940 | 63868-940-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LAURAMINE OXIDE | 4F6FC4MI8W | IACT |
| COCO DIETHANOLAMIDE | 92005F972D | IACT |
| PEG-75 LANOLIN | 09179OX7TB | IACT |
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | S38J6RZN16 | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| WATER | 059QF0KO0R | IACT |
| TRIDECYL ALCOHOL | 8I9428H868 | IACT |
| GLUCONOLACTONE | WQ29KQ9POT | IACT |
| CHLORHEXIDINE GLUCONATE | MOR84MUD8E | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | SOLUTION / TOPICAL | 0.3 %w/w | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | GEL / TOPICAL | 4 mg | ||
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | SOLUTION / TOPICAL | 0.3 %w/w | ||
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | SPONGE / TOPICAL | ADJ PH | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SOLUTION / TOPICAL | 2.5 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SHAMPOO / TOPICAL | 600 mg | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | SOLUTION / TOPICAL | 1 %w/w | ||
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | SPONGE / TOPICAL | ADJ PH | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | AEROSOL / TOPICAL | 1.5 %w/w | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SUSPENSION / TOPICAL | 4 %w/w | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SUSPENSION / TOPICAL | 0.69 %w/v | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SPONGE / TOPICAL | 2 %w/w | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SOLUTION / TOPICAL | 0.21 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | LOTION / TOPICAL | 0.2 %w/v | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | SOLUTION / TOPICAL | 1 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | CREAM / TOPICAL | 30 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SUSPENSION / TOPICAL | 0.69 %w/v | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | GEL / TOPICAL | 4 mg | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | EMULSION / TOPICAL | 1.5 %w/w | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SUSPENSION / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | CLOTH / TOPICAL | NA | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | EMULSION / TOPICAL | 1.5 %w/w | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SHAMPOO / TOPICAL | 600 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | LOTION / TOPICAL | 0.2 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SOLUTION / TOPICAL | 2.5 %w/v | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | AEROSOL / TOPICAL | 1.5 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SOLUTION / TOPICAL | 0.21 %w/v | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | SPONGE / TOPICAL | 2 %w/w | ||
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | CLOTH / TOPICAL | NA | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| COCO DIETHANOLAMIDE | COCO DIETHANOLAMIDE | 92005F972D | CREAM / TOPICAL | 30 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019125-001 | DYNA-HEX 4 | CHLORHEXIDINE GLUCONATE | 4% | SOLUTION / TOPICAL | 1984-12-24 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N019125-001 | DYNA-HEX 4 | 4% | SOLUTION / TOPICAL | 1984-12-24 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N019125-001 | DYNA-HEX 4 | 4% | SOLUTION / TOPICAL | 1984-12-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N019125-001 | DYNA-HEX 4 | 4% | SOLUTION / TOPICAL | 1984-12-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Antiseptic Skin Cleanser | CHLORHEXIDINE GLUCONATE 4% | Chain Drug Marketing Association Inc. | 12234b17-fd07-6088-e054-00144ff88e88 | 2025-12-12 | Warnings | 63868-940-08 63868-940 63868094008 45c51b33-4895-a56e-e063-6394a90aaf61 12234b17-fd07-6088-e054-00144ff88e88 |
Adverse event summaries are temporarily unavailable. Other product information remains available.